FDA Approves Supplemental Applications for TRELSTAR
The FDA has approved supplemental applications for TRELSTAR, a triptorelin pamoate product.
Therapeutic Area
Therapeutic area intelligence for Hormonal Therapy with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.